Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07301099Not Yet Recruiting

Epidemiology and Current Practices in Severe Community-Acquired Pneumonia

Role: collaborator

NCT02498587Recruiting

Short Period Incidence Study of Severe Acute Respiratory Illness

Role: collaborator

NCT04527458Completed

Case Fatalities in Hospitalised COVID-19 Patients in the UK

Role: collaborator

NCT02342171Phase 2Completed

Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea

Role: collaborator

All 4 trials loaded